Last reviewed · How we verify
NCT04890132
Vestibular Precision: Physiology & Pathophysiology
NA trial testing VOR precision training in Vestibular Schwannoma in 90 participants. Status unknown.
30 June 2025
Quick facts
| Lead sponsor | Massachusetts Eye and Ear Infirmary |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 90 |
| Start date | 1 July 2020 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- VOR precision training
Conditions studied
- Vestibular Schwannoma — all drugs for Vestibular Schwannoma →
- Inner Ear Disease — all drugs for Inner Ear Disease →
- Dizziness — all drugs for Dizziness →
- Neurofibromatosis 2 — all drugs for Neurofibromatosis 2 →
Sponsor
Massachusetts Eye and Ear Infirmary — full company profile →
Who can join
Adults 8 to 80, any sex, with Vestibular Schwannoma or Inner Ear Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will investigate the role of noise in the vestibular system, and in particular its effects on the variability (precision) of vestibular-mediated behaviors. The investigators will study vestibular precision in normal subjects and patients with peripheral vestibular damage, and will investigate its potential plasticity. The goals are to develop a better understanding of the role noise plays in the vestibular system in normal and pathologic populations, and to determine if the brain can learn to improve signal recognition within its inherently noisy neural environment, which would result in improved behavioral precision.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04890132
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vestibular Schwannoma
Currently open trials in the same condition.
- NCT07364955 — Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma · NA · recruiting
- NCT07130851 — Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma · NA · active not recruiting
- NCT06572475 — USPIO Enhanced MR Imaging in CNS Tumours (UMIC) · NA · recruiting
- NCT06112509 — Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery · NA · recruiting
- NCT05641441 — Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma · recruiting
Other Massachusetts Eye and Ear Infirmary trials
Trials by the same sponsor.
- NCT06926478 — Subconjunctival Humira for Boston Keratoprosthesis · Phase 1 · not yet recruiting
- NCT06425419 — The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy · Phase 1 · not yet recruiting
- NCT07383701 — Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema · Phase 2 · not yet recruiting
- NCT06688578 — Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait · NA · recruiting
- NCT06753916 — ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04890132 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Massachusetts Eye and Ear Infirmary
- Last refreshed: 16 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04890132.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing